focus -WSS

focus

author：comprehensive 2025-10-02 10:45:28 - browse：461

Abbott's heart device TriClip on a gradient dark blue background — coverage from STAT — The device is called the TriClip, and it addresses a disease called tricuspid regurgitation: a heart condition that causes blood to leak backward through the tricuspid heart valve. Illustration: STAT; Photo: Courtesy Abbott

An advisory panel to the Food and Drug Administration voted in favor of a new device from Abbott meant to treat patients with tricuspid heart valve disease. All but one of the 14 panelists said the treatment’s benefits outweighed its risks. The FDA tends to follow advisory panel recommendations.

“If we can help symptoms with this at a low cost in terms of risk, I think it makes a lot of sense,” said James Blankenship, a panelist and cardiologist at the University of New Mexico.

The device is called the TriClip, and it addresses a disease called tricuspid regurgitation: a heart condition that causes blood to leak backward through the tricuspid heart valve. The condition impacts 1.6 million people in the United States. Symptoms include fatigue, swelling, and atypical heart rhythms. In severe cases, the condition can lead to heart failure.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： Senate committee advances SCOTUS ethics bill after alleged justice misconduct

WSS

Wildfires rage amid heat wave in Greece, prompting evacuations and call for European support

There's no autism epidemic. It's an autism diagnosis epidemic

Why the world’s most expensive drug might be worth the price

Public funding for King Charles III and royals has been recalculated due to windfarm deal profits

7 more heat

Key lawmaker blasts Congress’ efforts on addiction: ‘Shame on us’

knowledge

focus

leisure time

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Ending racial health disparities hinges on penalties, political will

Medical records are filled with copy

Why Congress must ban federal programs from using QALYs

Trump demands the U.S. pay no more for drugs than other countries … again

FDA's naming rule on biosimilars has undermined competition

23andMe had bad news about my health. I wish a person had delivered it

The Readout: Lenmeldy, GLP

Supreme Court strikes down use of affirmative action

Tesla recalling nearly 16,000 of its 2021

knowledge

Supreme Court mifepristone arguments center on docs' right to sue

Winning ticket for $1 billion Powerball jackpot sold in California

I learned firsthand about improving diversity in clinical trials

Readout Newsletter: Merck, Vertex, and Viking updates

Primary care physicians play key roles in Alzheimer's management

Eliminate the waiting period for sterilization covered by Medicaid

focus

focus

hotspot

focus